We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
-2.5%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
–
Cap. Flow
+$230M
Cap. Flow
% of AUM
107.56%
Top 10 Holdings %
Top 10 Hldgs %
83.52%
Holding
15
New
15
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$28.5M |
| 2 |
Viridian Therapeutics
VRDN
|
+$24.5M |
| 3 |
Cogent Biosciences
COGT
|
+$23.9M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
+$22.4M |
| 5 |
Tyra Biosciences
TYRA
|
+$16.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $29.1M | 13.63% |
+1,741,228
| New | +$28.5M |
|
|
2
Viridian Therapeutics
VRDN
$2.01B
| $26M | 12.16% |
+1,314,000
| New | +$24.5M |
|
|
3
Cogent Biosciences
COGT
$6.61B
| $23.6M | 11.05% |
+2,750,037
| New | +$23.9M |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $20M | 9.35% |
+5,905,400
| New | +$22.4M |
|
|
ALPN
5
DELISTED
Alpine Immune Sciences Inc
ALPN
| $16.2M | 7.59% |
+1,170,212
| New | +$14.5M |
|
6
Aclaris Therapeutics
ACRS
$765M
| $15.7M | 7.37% |
+1,082,213
| New | +$16.4M |
|
|
KDNY
7
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $14.4M | 6.74% |
+882,353
| New | +$12.6M |
|
|
8
Tyra Biosciences
TYRA
$1.89B
| $12M | 5.6% |
+850,450
| New | +$16.9M |
|
9
Entrada Therapeutics
TRDA
$273M
| $11.4M | 5.32% |
+663,694
| New | +$16.1M |
|
|
JBIO
10
Jade Biosciences
JBIO
$1.29B
| $10.1M | 4.71% |
+24,381
| New | +$12.3M |
|
11
Dianthus Therapeutics
DNTH
$5.35B
| $9.84M | 4.61% |
+138,889
| New | +$14M |
|
|
AKUS
12
DELISTED
Akouos Inc
AKUS
| $8.88M | 4.16% |
+1,045,215
| New | +$9.37M |
|
|
MRUS
13
DELISTED
Merus
MRUS
| $7.16M | 3.35% |
+225,000
| New | +$6.36M |
|
14
Zai Lab
ZLAB
$2.34B
| $5.97M | 2.8% |
+95,000
| New | +$8.06M |
|
|
ELEV
15
DELISTED
Elevation Oncology
ELEV
| $3.34M | 1.56% |
+555,000
| New | +$3.83M |
|
Similar funds
DILIC
IIM
ACM
BCP
AL
ACA
MSC
TH